glp 1 epilepsy Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in and associated comorbidities Could GLP-1 drugs affect risk

Symptomatic atherosclerosis is associated with an altered gut metagenome

Peirson Center for Children

[L-carnitine therapy and myocardial function in children treated with chronic hemodialysis]

No findings suggest clinical relevance, therapeutic intent, physiological application, or suitability for human or veterinary use

MSCs can go beyond their traditional roles in tissue repair, immune modulation, and paracrine signaling to intricately engage in fighting the multifaceted processes associated with aging, making them particularly promising for future clinical trials, especially in the fields of regenerative medicine and anti-aging treatments[17-19]